Ján Varga

Ján Varga

Auto-generated profile, based on publicly available information

Ján Varga

Department of Gynecology and Obstetrics, Faculty of Medicine, P. J. Šafárik University and L. Pasteur University Hospital, Košice, Slovakia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
ŠTŠtefan Tóth
Štefan Tóth
TPTímea Pekárová
Tímea Pekárová
JVJán Varga
Ján Varga
VTVladimíra Tomečková
Vladimíra Tomečková
Peter GalPeter Gal
Peter Gal
JGJuraj Guzy
Juraj Guzy

1 January 2025 in Case Reports in Obstetrics and Gynecology
Verified
Journal Article
Open access
NMNatalia Milczarska
Natalia Milczarska
JVJán Varga
Ján Varga
KJKarolina Just
Karolina Just
AOAlexander Ostró
Alexander Ostró
Introduction: Müllerian agenesis, also known as vaginal agenesis, Müllerian aplasia, or Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome, is a rare developmental disorder affecting one in 5000 female births, resulting from an error in Müllerian duct fusion during fetal development. Case Report: We present a clinical case of a 46‐year‐old female patient, virgo intacta, with Müllerian agenesis and a leiomyoma arising from remnant uterine buds. The patient presented with primary amenorrhoea, continuous lower abdominal pain, and abdominal distension. We describe the diagnostic process and treatment strategy. Discussion: MRKH syndrome is the leading cause of vaginal agenesis, often accompanied by uterine and cervical aplasia. It is categorized into Type 1, which involves symmetric underdevelopment of the Müllerian ducts, and Type 2, characterized by asymmetric malformations of the genital tract and other congenital anomalies. Leiomyomas arising from remnant uterine tissue in MRKH patients are extremely rare. Accurate diagnosis and a carefully planned treatment strategy are essential for managing patients with MRKH syndrome complicated by rare tumors. Conclusion: In this case, total tumor extirpation with bilateral adnexectomy was the preferred treatment, based on the patient′s clinical presentation and diagnosis.

29 January 2026 in Case Reports in Obstetrics and Gynecology
Verified
Journal Article
Open access
JVJán Varga
Ján Varga
KJKarolina Just
Karolina Just
AOAlexander Ostró
Alexander Ostró
Objective: Uterine leiomyoma represents one of the most common pathologies affecting women of reproductive age, often presenting with lower abdominal pain and abnormal bleeding. Benign metastasising leiomyomatosis (BML) is a rare tumour originating from uterine leiomyomas, with the lungs being a common extrauterine location. The aetiopathogenesis remains unclear, and no standardised treatment protocols exist due to the rarity of the disease. Case Report: We present a case of a patient who developed pulmonary BML 7 years after hysterectomy for uterine leiomyoma. Despite initial hormonal therapy and various interventions, the patient′s condition progressively worsened, leading to pulmonary hypertension, cardiac decompensation and ultimately death. Despite consultations with oncologists and treatment with aromatase inhibitors and doxorubicin, the disease proved refractory to treatment. Conclusion: BML remains a challenging condition to manage due to its low incidence and lack of standardised treatment protocols. Multidisciplinary approaches are essential, and further research is needed to establish better treatment guidelines.